Melissa officinalis L. as a Nutritional Strategy for Cardioprotection
- PMID: 33967832
- PMCID: PMC8100328
- DOI: 10.3389/fphys.2021.661778
Melissa officinalis L. as a Nutritional Strategy for Cardioprotection
Abstract
This review aimed to provide a summary on the traditional uses, phytochemistry, and pharmacological activities in the cardiovascular system and cardiotoxicity of Melissa officinalis (MO), with the special emphasis on the protective mechanisms in different cardiovascular pathologies. MO is a perennial aromatic herb commonly known as lemon balm, honey balm, or bee balm, which belongs to Lamiaceae family. Active components are mainly located in the leaves or essential oil and include volatile compounds, terpenoid (monoterpenes, sesquiterpenes, triterpenes), and polyphenolic compounds [rosmarinic acid (RA), caffeic acid, protocatechuic acid, quercitrin, rhamnocitrin, luteolin]. For centuries, MO has been traditionally used as a remedy for memory, cognition, anxiety, depression, and heart palpitations. Up until now, several beneficial cardiovascular effects of MO, in the form of extracts (aqueous, alcoholic, and hydroalcoholic), essential oil, and isolated compounds, have been confirmed in preclinical animal studies, such as antiarrhythmogenic, negative chronotropic and dromotropic, hypotensive, vasorelaxant, and infarct size-reducing effects. Nonetheless, MO effects on heart palpitations are the only ones confirmed in human subjects. The main mechanisms proposed for the cardiovascular effects of this plant are antioxidant free radical-scavenging properties of MO polyphenols, amelioration of oxidative stress, anti-inflammatory effects, activation of M2 and antagonism of β1 receptors in the heart, blockage of voltage-dependent Ca2+ channels, stimulation of endothelial nitric oxide synthesis, prevention of fibrotic changes, etc. Additionally, the main active ingredient of MO-RA, per se, has shown substantial cardiovascular effects. Because of the vastness of encouraging data from animal studies, this plant, as well as the main ingredient RA, should be considered and investigated further as a tool for cardioprotection and adjuvant therapy in patients suffering from cardiovascular diseases.
Keywords: Melissa officinalis; cardioprotection; lemon balm; myocardium; polyphenols.
Copyright © 2021 Draginic, Jakovljevic, Andjic, Jeremic, Srejovic, Rankovic, Tomovic, Nikolic Turnic, Svistunov, Bolevich and Milosavljevic.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Lemon balm (Melissa officinalis L.) essential oil and citronellal modulate anxiety-related symptoms - In vitro and in vivo studies.J Ethnopharmacol. 2022 Feb 10;284:114788. doi: 10.1016/j.jep.2021.114788. Epub 2021 Oct 28. J Ethnopharmacol. 2022. PMID: 34718102
-
Evaluation of the anti-nociceptive profile of essential oil from Melissa officinalis L. (lemon balm) in acute and chronic pain models.J Ethnopharmacol. 2024 Mar 1;321:117500. doi: 10.1016/j.jep.2023.117500. Epub 2023 Nov 27. J Ethnopharmacol. 2024. PMID: 38030022
-
Melissa officinalis ssp. altissima extracts: A therapeutic approach targeting psoriasis in mice.J Ethnopharmacol. 2020 Jan 10;246:112208. doi: 10.1016/j.jep.2019.112208. Epub 2019 Aug 30. J Ethnopharmacol. 2020. PMID: 31476443
-
Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology.J Ethnopharmacol. 2016 Jul 21;188:204-28. doi: 10.1016/j.jep.2016.05.010. Epub 2016 May 7. J Ethnopharmacol. 2016. PMID: 27167460 Review.
-
Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems-A Review.Int J Mol Sci. 2022 Mar 25;23(7):3591. doi: 10.3390/ijms23073591. Int J Mol Sci. 2022. PMID: 35408950 Free PMC article. Review.
Cited by
-
Clinical Efficacy and Tolerability of Lemon Balm (Melissa officinalis L.) in Psychological Well-Being: A Review.Nutrients. 2024 Oct 18;16(20):3545. doi: 10.3390/nu16203545. Nutrients. 2024. PMID: 39458539 Free PMC article. Review.
-
Ethnobotanical, Phytochemical, and Pharmacological Properties of the Subfamily Nepetoideae (Lamiaceae) in Inflammatory Diseases.Plants (Basel). 2023 Nov 2;12(21):3752. doi: 10.3390/plants12213752. Plants (Basel). 2023. PMID: 37960108 Free PMC article. Review.
-
Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account.Int J Mol Sci. 2024 Jul 8;25(13):7477. doi: 10.3390/ijms25137477. Int J Mol Sci. 2024. PMID: 39000584 Free PMC article. Review.
-
Melissa officinalis L. Supplementation Provides Cardioprotection in a Rat Model of Experimental Autoimmune Myocarditis.Oxid Med Cell Longev. 2022 Feb 28;2022:1344946. doi: 10.1155/2022/1344946. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35265259 Free PMC article.
-
Short-Term Administration of Lemon Balm Extract Ameliorates Myocardial Ischemia/Reperfusion Injury: Focus on Oxidative Stress.Pharmaceuticals (Basel). 2022 Jul 8;15(7):840. doi: 10.3390/ph15070840. Pharmaceuticals (Basel). 2022. PMID: 35890139 Free PMC article.
References
-
- Abdel-Naime W. A., Fahim J. R., Fouad M. A., Kamel M. S. (2016). Botanical studies of the leaf of Melissa officinalis L., Family: labiatae, cultivated in Egypt. J. Pharm. Phytochem. 5 98–104.
-
- Abdel-Naime W. A., Fahim J. R., Fouad M. A., Kamel M. S. (2020). Botanical studies on the stem and root of Melissa officinalis L. (lemon balm). J. Adv. Biomed. Pharm. Sci. 3 184–189. 10.21608/jabps.2020.29774.1085 - DOI
-
- Aharizad S., Rahimi M. H., Moghadam M., Mohebalipour N. (2012). Study of genetic diversity in lemon balm (Melissa officinalis l.) populations based on morphological traits and essential oils content. Ann. Biol. Res. 3 5748–5753.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous